CNW — CoDon AG Share Price
Last trade - 00:00- €0.17m
- €5.18m
- €9.80m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.03 | ||
| Price to Tang. Book | 0.03 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.02 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -105.88% | ||
| Return on Equity | -134.62% | ||
| Operating Margin | -133.86% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 6.33 | 5.65 | 6.86 | 6.23 | 9.8 | n/a | n/a | 11.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CoDon AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. It also offers biopsy, cultivation, transplantation, rehabilitation and others.
Directors
- Hans Bauerfeind CSU
- Thommy Staehlin VSU
- Tilmann Bur MGB (56)
- Hans-Joachim Simons MGB
- Hans-Joerg Bullinger IND (78)
- Thomas Krause IND
- Barbara Sickmueller IND
- Beatrix Bauerfeind-Johnson SUB
- Last Annual
- December 31st, 2021
- Last Interim
- June 30th, 2022
- Incorporated
- September 14th, 1999
- Public Since
- February 1st, 2001
- No. of Employees
- 134
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Frankfurt Stock Exchange
- Shares in Issue
- 26,723,248.91
- Address
- Warthestrasse 21, TELTOW, 14513
- Web
- https://www.codon.de/
- Phone
- +49 332843460
- Contact
- Matthias Meissner
- Auditors
- Mazars GmbH Wirtschaftsprufungsgesellschaft
Upcoming Events for CNW
Similar to CNW
Apontis Pharma AG
Frankfurt Stock Exchange
Bayer AG
Frankfurt Stock Exchange
FAQ
As of Today at 20:01 UTC, shares in CoDon AG are trading at €0.01. This share price information is delayed by 15 minutes.
Shares in CoDon AG last closed at €0.01 and the price had moved by -73.58% over the past 365 days. In terms of relative price strength the CoDon AG share price has underperformed the FTSE Global All Cap Index by -77.2% over the past year.
The overall consensus recommendation for CoDon AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCoDon AG does not currently pay a dividend.
CoDon AG does not currently pay a dividend.
CoDon AG does not currently pay a dividend.
To buy shares in CoDon AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.01, shares in CoDon AG had a market capitalisation of €0.17m.
Here are the trading details for CoDon AG:
- Country of listing: Germany
- Exchange: FRA
- Ticker Symbol: CNW
Based on an overall assessment of its quality, value and momentum CoDon AG is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in CoDon AG is €7.50. That is 115284.62% above the last closing price of €0.01.
Analysts covering CoDon AG currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CoDon AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -48.76%.
As of the last closing price of €0.01, shares in CoDon AG were trading -54.77% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CoDon AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CoDon AG's management team is headed by:
- Hans Bauerfeind - CSU
- Thommy Staehlin - VSU
- Tilmann Bur - MGB
- Hans-Joachim Simons - MGB
- Hans-Joerg Bullinger - IND
- Thomas Krause - IND
- Barbara Sickmueller - IND
- Beatrix Bauerfeind-Johnson - SUB